• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Custom Antibody Market

    ID: MRFR/HC/5597-HCR
    85 Pages
    Kinjoll Dey
    September 2025

    Custom Antibody Market Research Report Information By Service (Antibody Development, Antibody Production & Purification, and Antibody Fragmentation & Labelling), By Source (Mice and Others), By Research Area (Oncology, Neurobiology, Infectious Diseases, Immunology, and Others), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibody, and Other Custom Antibodies), By End Users (Hospitals & Clinics, Academic & Research Institute, Contact Research Organization, Biotechnology Companies, and Others), And By Reg...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Custom Antibody Market Research Report – Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Custom Antibody Market Summary

    The Global Custom Antibody Market is projected to grow from 0.15 USD Billion in 2024 to 0.39 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Custom Antibody Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 8.96% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 0.39 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.15 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of custom antibodies due to increasing research and development activities is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.15 (USD Million)
    2035 Market Size 0.39 (USD Million)
    CAGR (2025-2035) 8.96%

    Major Players

    Thermo Fisher Scientific Inc, Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories Inc, Cell Signaling Technology Inc, Agilent Technologies Inc, Biolegend Inc, Rockland Immunochemicals Inc, Promab Biotechnologies Inc

    Custom Antibody Market Trends

      • Growing companies offering R&D services for custom antibodies to drive market growth

    Custom antibodies can be used for both qualitative and quantitative immune detection. Custom antibodies outperform regularly cultured antibodies in terms of selectivity and specificity. Moreover, these custom antibodies are relatively easy to produce compared to other antibodies, making them a popular choice for various research studies. Customized antibodies can be produced in hamsters, mice, or rats to meet host requirements. The adaptive immune system produces antibodies in response to invading pathogens. The offending virus, bacteria, or other molecules are locked and unlocked by the antibody's specific lock and critical recognition.

    Researchers worldwide are conducting various types of research focused on using this physiological process of the human body to produce unique antibodies in response to antigens that describe particular infections or medical conditions. Companies offer a diverse range of antibodies based on the researcher's needs.

    The industry's growing research efforts in biology and the life sciences are driving factors for market expansion. Patients' rapidly increasing awareness of the efficacy of the drugs is also contributing to market growth. Moreover, the growing adoption of immunotherapeutic and targeted therapy due to their efficacy and common complications drives the custom antibody market CAGR growth. Customized medications have gained popularity for treating cancer and other chronic diseases. As a result, the utilization of personalized antibodies is increasing, fueling market growth. For example, MonoRab, a novel rabbit mAB, was introduced by GenScript in June 2021.

    The technologies involved are mAB sequencing and hybridoma. It is more affine and has higher specificity in a variety of applications. Growing government funding and support, advancements in biotechnology research, shifting disease profiles, and expanded public and private partnerships contribute to custom antibody market revenue growth.

    The Global Custom Antibody Market is poised for growth as advancements in biotechnology and personalized medicine drive demand for tailored therapeutic solutions.

    National Institutes of Health (NIH)

    Custom Antibody Market Drivers

    Market Growth Projections

    The Global Custom Antibody Market Industry is projected to experience substantial growth over the coming years. With a market value anticipated to rise from 0.15 USD Billion in 2024 to 0.39 USD Billion by 2035, the industry is poised for a robust expansion. This growth trajectory reflects a compound annual growth rate (CAGR) of 8.96% from 2025 to 2035. Such projections underscore the increasing importance of custom antibodies in various applications, including research, diagnostics, and therapeutics, as the demand for innovative healthcare solutions continues to escalate.

    Emerging Markets and Globalization

    The Global Custom Antibody Market Industry is experiencing growth due to the emergence of new markets and globalization. As developing countries invest in healthcare infrastructure and research capabilities, the demand for custom antibodies is expected to increase. This trend is particularly evident in regions such as Asia-Pacific and Latin America, where rising healthcare expenditures and a growing focus on biotechnology are driving market expansion. The globalization of the biopharmaceutical industry further facilitates access to advanced technologies and expertise, potentially enhancing the production and application of custom antibodies on a global scale.

    Rising Demand for Personalized Medicine

    The Global Custom Antibody Market Industry is experiencing a notable surge in demand for personalized medicine. This trend is driven by advancements in biotechnology and an increasing understanding of the human genome. Personalized medicine allows for tailored therapeutic approaches, enhancing treatment efficacy. As a result, the market is projected to grow from 0.15 USD Billion in 2024 to 0.39 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.96% from 2025 to 2035. This growth is indicative of the industry's potential to meet the specific needs of patients, thereby fostering innovation in drug development.

    Increased Funding for Research and Development

    The Global Custom Antibody Market Industry is benefiting from increased funding for research and development across various sectors, including pharmaceuticals and biotechnology. Governments and private entities are investing significantly in R&D initiatives aimed at discovering new therapeutic targets and developing innovative treatments. This influx of capital is expected to accelerate the development of custom antibodies, which are crucial for targeted therapies. As a result, the market is poised for substantial growth, with projections indicating a rise from 0.15 USD Billion in 2024 to 0.39 USD Billion by 2035, driven by the need for advanced therapeutic solutions.

    Technological Advancements in Antibody Production

    Technological innovations in antibody production are significantly influencing the Global Custom Antibody Market Industry. Techniques such as phage display and hybridoma technology have revolutionized the way custom antibodies are generated, leading to increased efficiency and specificity. These advancements not only enhance the quality of antibodies but also reduce production costs, making them more accessible for research and therapeutic applications. As the industry continues to evolve, the integration of automation and artificial intelligence in antibody development processes is likely to further streamline production, thereby expanding market opportunities and driving growth.

    Growing Applications in Diagnostics and Therapeutics

    The Global Custom Antibody Market Industry is witnessing an expansion in applications across diagnostics and therapeutics. Custom antibodies are increasingly utilized in various diagnostic assays, including ELISA and Western blotting, which are essential for disease detection and monitoring. Furthermore, their role in therapeutic applications, such as targeted cancer therapies, is becoming more pronounced. This diversification of applications is likely to contribute to the market's growth trajectory, with estimates suggesting a rise from 0.15 USD Billion in 2024 to 0.39 USD Billion by 2035, highlighting the importance of custom antibodies in modern healthcare.

    Market Segment Insights

    Custom Antibody Service Insights

    Based on service, the market segments of custom antibody includes antibody development, antibody production & purification, and antibody fragmentation & labeling. The antibody development segment held the majority share in 2022, contributing around ~42-45% to the custom antibody market revenue owing to the expansion of biotechnology and biopharmaceutical companies. The growing emphasis of researchers on high-quality, specially designed antibodies for reproducibility, which can be crippled when using commercially available antibodies, can be attributed to the large share of this segment. Additionally, increased R&D activities for developing targeted antibodies are expected to drive market expansion over the projection period.

    Figure 1: Custom Antibody Market, by Service, 2022 & 2032 (USD Billion)

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    Custom Antibody Source Insights

    Based on the source, the custom antibody market segmentation includes mice and others. The mice segment dominated the market in 2022 and is likely to be the faster-growing segment during the forecast period, 2024-2032. Mice are the most used hosts to produce research-use antibodies. Compared to other experimental sources, mice have lower feeding costs and are easier to maintain and handle due to their small size. They produce human-like IgA, IgE, IgD, IgG, and IgM antibody isotypes. In addition, laboratory mice can elicit a robust immune response to various antigens, including highly homologous human proteins.

    Besides, certain medications that are illegal to use on humans can be used legally on mice with results comparable to humans. Mice have previously played an essential role in discovering and pre-clinical evaluation of monoclonal antibodies, owing to the pharmaceutical industry's rapid production of therapeutic antibodies.

    October 2022: Taconic Biosciences has announced the release of the FcResolv NOG portfolio, an immunodeficient mice model lacking murine Fc gamma receptors. The product enables scientists to evaluate potential candidates without interfering with lingering murine Fc gamma receptor activity, which the company claims is anticipated to promote antibody-based therapeutic approaches during the preclinical stage for the custom antibody industry.

    Custom Antibody Research Area Insights

    Research areas have bifurcated the custom antibody market data into oncology, neurobiology, infectious diseases, immunology, and others. The oncology segment dominated the market in 2022 and is predicted to be the faster-growing segment during the forecasted period 2024-2032. The rising cancer incidence rate and advancements in personalized treatment are projected to be key growth drivers in the oncology application segment of the custom antibodies market. Oncology is the most innovative therapeutic field regarding clinical trial activity, the number of companies investing in therapeutic applications, clinical advancement, the introduction of novel active substances, and the cost of these drugs.

    Cancer is one of the most prevalent causes of mortality, which has resulted in advances in cancer research and an increase in the proportion of therapeutic mAbs in clinical trials and research. This factor is responsible for a significant proportion of the oncology segment market growth.

    Custom Antibody Type Insights

    The custom antibody industry has been segmented based on type into monoclonal, polyclonal, recombinant, and other custom antibodies. Monoclonal held the most prominent segment share in 2022. Monoclonal antibodies are one of the most effective biologics used for various purposes. These compounds' high selectivity, specificity, and binding affinity frequently make them valuable, and researchers in all research studies prefer them. Additionally, monoclonal antibodies are molecules created in a lab that act as substitutes and can boost, restore, mimic, or alter the immune system's attack on undesirable cells, such as cancer cells.

    They are also designed to bind to antigens that are more numerous on the surface of cancer cells than on the surface of healthy cells. Furthermore, polyclonal antibodies have advantages such as easy storage, high affinity, stability, and suitability for western and ELISA blotting technologies.

    Custom Antibody End User Insights

    Based on end users, the custom antibody industry has been segmented into hospitals & clinics, academic & research institutes, contract research organizations, and biotechnology companies. Biotechnology companies held the highest segment revenue share in 2022. This is attributed to the growing demand for specific antibodies for drug discovery and development, genome and bioinformatics research development, and the expansion of research and development efforts in multiple therapeutic fields. An antibody is a protein naturally produced by the immune system in response to an infection.

    A monoclonal antibody is a substance developed in a lab that imitates or boosts the immune system's defenses against an adversary like cancer or an infection. Monoclonal antibodies benefit over other infection treatment methods in that they are created to directly target a crucial element of the infectious process.

    Get more detailed insights about Custom Antibody Market Research Report – Forecast till 2032

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Custom Antibody market accounted for USD 0.073 billion in 2022 and is projected to exhibit a significant CAGR growth over the study period. The North American region's dominance can be attributed to increased investments in the development of structure-based drug designs, expanded genomics and proteomics research, increased demand for high-quality research tools for data reproducibility, rising interest in the development of antibody-based therapeutics, and the presence of several international players in this region.

    Also, the region has a vast number of clinical research organizations that are associated with the development of new therapeutic antibodies. These have accelerated progress in the biotechnology sector, increasing demand for high-throughput technology solutions in laboratory workflows. North America's market dominance is anticipated to remain unchallenged during the forecast period due to the region's rapid adoption of cutting-edge technological solutions, significant investments in R&D, and rising wages for highly qualified workers.

    Further, the major countries studied in the market report are the U.S., Germany, Canada, the UK, Italy, France, Spain, China, Japan, Australia, India, South Korea, and Brazil.

    Figure2: CUSTOM ANTIBODY MARKET SHARE BY REGION 2022 (%)CUSTOM ANTIBODY MARKET SHARE BY REGION 2022 (%)

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    European custom antibody market accounts for the second-largest market share. Factors such as increased research expenses, technological advancement, a decline in human health, and the need for innovative and effective therapies all contribute to this region's growth. According to Capra Science, a European company specializing in custom antibody production, llama-derived nanobodies may have therapeutic applications in Parkinson's disease. As a result, increased R&D activities drive demand for custom antibodies and revenue growth in the European market.

    Further, the German market of custom antibody held the largest market share, and the UK market of custom antibody was the fastest-growing market in the European region.

    The Asia-Pacific Custom Antibody Market is projected to grow at the fastest CAGR between 2024 and 2032. This is primarily due to increased government and business investment, biotechnology research expansion, and awareness of personalized therapeutics. Due to economic developments, China and India receive more investments from international investors. Similarly, regional players are expanding their presence in the market for custom antibodies. Moreover, the China market of custom antibody held the largest market share, and the Indian market of custom antibody was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players will likely assist end users with the development process by advancing technology in their workflow. Key custom antibody industry players now have several opportunities to profit from the ongoing demand for custom antibodies from numerous end users. The custom antibody market major players, including Genscript, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Merck Group, and others, are working to increase market demand by investing in research and development.

    The custom antibody industry is relatively consolidated, with a small number of large and medium-sized players accounting for most of the market revenue. Major players are implementing various market development strategies, including mergers and acquisitions, strategic agreements, and contracts, increasing R&D activities, and developing, testing, and introducing more effective custom antibody products. In recent years, the custom antibody industry has supplied some of the most significant benefits to recombinant antibodies.

    Thermo Fisher Scientific Inc is an American manufacturer and distributor of scientific instruments, reagents, consumables, and software services. Thermo Fisher Scientific and BATL at Northeastern University signed a collaboration agreement in 2020 to advance analytical capabilities and drive innovation in the biopharmaceutical industry in areas such as personalized medicine, monoclonal custom antibodies, and gene & cell therapies.

    Also, Absolute Antibody Ltd is a company that specializes in custom antibody sequence analysis, expression, and engineering. The business announced in August 2022 that it would expand its production facility by adding lab space and funding automated technology like next-generation sequence analysis, purification, and expression. The expansion is anticipated to enhance the recombinant antibody production process.

    Key Companies in the Custom Antibody Market market include

    Industry Developments

    • Q2 2025: BioNTech and Bristol Myers Squibb sign global collaboration to co-develop and co-commercialize BNT327, a next-generation bispecific antibody for solid tumors BioNTech and Bristol Myers Squibb announced a global partnership to co-develop and co-commercialize BNT327, BioNTech’s PD‑L1 × VEGF‑A bispecific antibody, targeting multiple solid tumor types.
    • Q2 2024: BioNTech launches BNT327, a novel bispecific antibody targeting PD-L1 and VEGF-A for cancer immunotherapy BioNTech launched BNT327, a next-generation bispecific antibody designed to simultaneously target PD-L1 and VEGF-A, aiming to enhance immunotherapy efficacy in solid tumors.
    • Q2 2024: Abcam appoints new CEO to drive custom antibody business expansion Abcam announced the appointment of a new Chief Executive Officer, signaling a strategic focus on expanding its custom antibody services and global reach.
    • Q1 2024: Bio-Techne opens new antibody production facility in Minnesota Bio-Techne inaugurated a state-of-the-art antibody manufacturing facility in Minnesota to meet rising demand for custom antibody solutions in research and diagnostics.
    • Q2 2024: Thermo Fisher Scientific launches new custom recombinant antibody platform Thermo Fisher Scientific introduced a new platform for custom recombinant antibody production, offering faster turnaround and higher specificity for research and clinical applications.
    • Q2 2024: GenScript Biotech wins major contract to supply custom antibodies for global vaccine initiative GenScript Biotech secured a significant contract to provide custom antibodies for a multinational vaccine development program, expanding its footprint in the biopharma sector.
    • Q1 2025: Bio-Rad Laboratories acquires antibody startup for $120 million Bio-Rad Laboratories completed the acquisition of a startup specializing in custom antibody engineering, strengthening its portfolio in precision diagnostics and therapeutics.
    • Q2 2024: BioNTech receives EMA fast-track designation for custom bispecific antibody therapy BioNTech was granted fast-track designation by the European Medicines Agency for its custom bispecific antibody therapy targeting solid tumors, accelerating its regulatory pathway.
    • Q2 2024: Thermo Fisher Scientific partners with leading academic center for custom antibody R&D Thermo Fisher Scientific entered a partnership with a major academic institution to co-develop custom antibodies for advanced cancer and neurodegenerative disease research.
    • Q1 2025: Abcam secures $50 million funding to expand custom antibody manufacturing capacity Abcam raised $50 million in new funding to scale up its custom antibody production facilities, aiming to meet growing demand from pharmaceutical and biotech clients.
    • Q2 2024: GenScript Biotech launches new synthetic antibody library for custom research applications GenScript Biotech unveiled a new synthetic antibody library, enabling researchers to rapidly generate highly specific custom antibodies for diverse biomedical applications.
    • Q2 2025: Bio-Techne announces partnership with pharma company for custom antibody development in autoimmune diseases Bio-Techne entered a strategic partnership with a leading pharmaceutical company to co-develop custom antibodies targeting novel biomarkers in autoimmune disease therapeutics.

    Future Outlook

    Custom Antibody Market Future Outlook

    The Global Custom Antibody Market is projected to grow at 8.96% CAGR from 2024 to 2035, driven by advancements in biotechnology, increased R&D investments, and rising demand for personalized medicine.

    New opportunities lie in:

    • Develop innovative antibody engineering technologies to enhance specificity and efficacy.
    • Expand service offerings to include rapid turnaround times for custom antibody production.
    • Leverage partnerships with academic institutions for cutting-edge research collaborations.

    By 2035, the Custom Antibody Market is expected to be robust, reflecting substantial growth and innovation.

    Market Segmentation

    Custom Antibody Type Outlook

    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibody
    • Other Custom Antibodies

    Custom Antibody Source Outlook

    • Mice
    • Others

    Custom Antibody Service Outlook

    • Antibody Development
    • Antibody Production & Purification
    • Antibody Fragmentation & Labelling

    Custom Antibody Regional Outlook

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America

    Custom Antibody End Users Outlook

    • Biotechnology Companies
    • Hospital & Clinics
    • Academic & Research Institute
    • Contact Research Organizations
    • Others

    Custom Antibody Research Area Outlook

    • Oncology
    • Neurobiology
    • Infectious Diseases
    • Immunology
    • Others

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 0.14 billion
    Market Size 2024 USD 0.15 billion
    Market Size 2032 USD 0.30 billion
    Compound Annual Growth Rate (CAGR) 8.72% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018 - 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends
    Segments Covered Service, Source, Research Area, Type, End Users, and Region
    Geographies Covered Europe, North America, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Germany, Canada, U.K., Italy, France, Spain, Japan, China, Australia, India, South Korea, and Brazil
    Key Companies Profiled Thermo Fisher Scientific Inc, Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories Inc, Cell Signaling Technology Inc, Agilent Technologies Inc, Biolegend Inc, Rockland Immunochemicals Inc, Promab Biotechnologies Inc
    Key Market Opportunities Increasing demand from both pharmaceutical and biotechnology companies for therapeutics based on antibodies Expanding the availability of customized services for the creation of custom antibodies
    Key Market Dynamics Growing demands for personalized diagnostic and treatments Rising research activity in the life sciences industry

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    How much is the custom antibody market?

    The custom antibody market size was valued at USD 0.14 Billion in 2023.

    What is the growth rate of the custom antibody market?

    The market is likely to grow at a CAGR of 8.72% during the forecast period, 2024-2032.

    Which region held the largest market share in the custom antibody market?

    North America had the largest share of the market.

    Who are the key players in the custom antibody market?

    The key players in the market are Thermo Fisher Scientific Inc, Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories Inc, Cell Signaling Technology Inc, Agilent Technologies Inc, Biolegend Inc, Rockland Immunochemicals Inc, Promab Biotechnologies Inc.

    Which service led the custom antibody market?

    The antibody development category dominated the market in 2023.

    Which end users had the largest market share in the custom antibody market?

    Biotechnology companies had the largest revenue share of the market.

    1. Chapter 1. Report Prologue
    2. Chapter 2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    4. Chapter 4. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    5. Chapter 5. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    6. Chapter 6. Global Custom Antibody Market, by Service
      1. Introduction
      2. Antibody Development
        1. Antibody Characterization
    7. Market Estimates & Forecast, by Region, 2023-2030
    8. Market Estimates & Forecast, by Country, 2023-2030
      1. Antigen Preparation
    9. Market Estimates & Forecast, by Region, 2023-2030
    10. Market Estimates & Forecast, by Country, 2023-2030
      1. Immunization & Hybridoma Production
    11. Market Estimates & Forecast, by Region, 2023-2030
    12. Market Estimates & Forecast, by Country, 2023-2030
      1. Antibody Production & Purification
    13. Market Estimates & Forecast, by Region, 2023-2030
    14. Market Estimates & Forecast, by Country, 2023-2030
      1. Antibody Fragmentation & Labeling
    15. Market Estimates & Forecast, by Region, 2023-2030
    16. Market Estimates & Forecast, by Country, 2023-2030
    17. Chapter 7. Global Custom Antibody Market, by Source
      1. Introduction
      2. Mice
    18. Market Estimates & Forecast, by Region, 2023-2030
    19. Market Estimates & Forecast, by Country, 2023-2030
      1. Rabbits
    20. Market Estimates & Forecast, by Region, 2023-2030
    21. Market Estimates & Forecast, by Country, 2023-2030
      1. Human beings
    22. Market Estimates & Forecast, by Region, 2023-2030
    23. Market Estimates & Forecast, by Country, 2023-2030
      1. Other Sources
    24. Market Estimates & Forecast, by Region, 2023-2030
    25. Market Estimates & Forecast, by Country, 2023-2030
    26. Chapter 8. Global Custom Antibody Market, by Type
      1. Introduction
      2. Monoclonal Antibodies
    27. Market Estimates & Forecast, by Region, 2023-2030
    28. Market Estimates & Forecast, by Country, 2023-2030
      1. Polyclonal Antibodies
    29. Market Estimates & Forecast, by Region, 2023-2030
    30. Market Estimates & Forecast, by Country, 2023-2030
      1. Recombinant Antibodies
    31. Market Estimates & Forecast, by Region, 2023-2030
    32. Market Estimates & Forecast, by Country, 2023-2030
      1. Other Custom Antibodies
    33. Market Estimates & Forecast, by Region, 2023-2030
    34. Market Estimates & Forecast, by Country, 2023-2030
    35. Chapter 9. Global Custom Antibody Market, by Research Area
      1. Introduction
      2. Oncology
    36. Market Estimates & Forecast, by Region, 2023-2030
    37. Market Estimates & Forecast, by Country, 2023-2030
      1. Infectious Diseases
    38. Market Estimates & Forecast, by Region, 2023-2030
    39. Market Estimates & Forecast, by Country, 2023-2030
      1. Immunology
    40. Market Estimates & Forecast, by Region, 2023-2030
    41. Market Estimates & Forecast, by Country, 2023-2030
      1. Neurobiology
    42. Market Estimates & Forecast, by Region, 2023-2030
    43. Market Estimates & Forecast, by Country, 2023-2030
      1. Stem Cells
    44. Market Estimates & Forecast, by Region, 2023-2030
    45. Market Estimates & Forecast, by Country, 2023-2030
      1. Cardiovascular Diseases
    46. Market Estimates & Forecast, by Region, 2023-2030
    47. Market Estimates & Forecast, by Country, 2023-2030
      1. Others
    48. Market Estimates & Forecast, by Region, 2023-2030
    49. Market Estimates & Forecast, by Country, 2023-2030
    50. Chapter 10. Global Custom Antibody Market, by End-Users
      1. Introduction
      2. Pharmaceutical & Biotechnology Companies
    51. Market Estimates & Forecast, by Region, 2023-2030
    52. Market Estimates & Forecast, by Country, 2023-2030
      1. Hospitals and Clinics
    53. Market Estimates & Forecast, by Region, 2023-2030
    54. Market Estimates & Forecast, by Country, 2023-2030
      1. Academic & Research Institutes
    55. Market Estimates & Forecast, by Region, 2023-2030
    56. Market Estimates & Forecast, by Country, 2023-2030
      1. Contract Research Organizations
    57. Market Estimates & Forecast, by Region, 2023-2030
    58. Market Estimates & Forecast, by Country, 2023-2030
      1. Others
    59. Market Estimates & Forecast, by Region, 2023-2030
    60. Market Estimates & Forecast, by Country, 2023-2030
    61. Chapter 11. Global Custom Antibody Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East & Africa
        1. Middle East
        2. Africa
    62. Chapter 12. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
    63. Chapter 13. Company Profiles
      1. Thermo Fisher Scientific Inc.
        1. Company Overview
        2. Product Overview
        3. Financials Overview
        4. Key Developments
        5. SWOT Analysis
      2. Genscript
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Abcam PLC
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Merck Group
        1. Company Overview
        2. Technology/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. Bio-Rad Laboratories, Inc.
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
      6. Cell Signaling Technology, Inc.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      7. Agilent Technologies, Inc.
        1. Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      8. Biolegend, Inc.
        1. Overview
        2. Service / Technology Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Rockland Immunochemicals Inc.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Promab Biotechnologies, Inc.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      11. Proteogenix
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      12. Innovagen Ab
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    64. Chapter 14 MRFR Conclusion
      1. Key Findings
        1. From CEO’s Viewpoint
        2. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Predictions for the Custom Antibody Industry
    65. Chapter 15. Appendix
    66. Billion)

    Custom Antibody Market Segmentation

    Custom Antibody Source Outlook (USD Billion, 2019-2030)

    • Mice
    • Others

    Custom Antibody Service Outlook (USD Billion, 2019-2030)

    • Antibody Development
    • Antibody Production & Purification
    • Antibody Fragmentation & Labelling

    Custom Antibody Research Area Outlook (USD Billion, 2019-2030)

    • Oncology
    • Neurobiology
    • Infectious Diseases
    • Immunology
    • Others

    Custom Antibody End Users Outlook (USD Billion, 2019-2030)

    • Hospitals & Clinics
    • Academic & Research Institute
    • Contact Research Organization
    • Biotechnology Companies
    • Others

    Custom Antibody Type Outlook (USD Billion, 2019-2030)

    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibody
    • Other Custom Antibodies

    Custom Antibody Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America Custom Antibody by Source
        • Mice
        • Others
      • North America Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • North America Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • North America Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • North America Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • US Outlook (USD Billion, 2019-2030)

      • US Custom Antibody by Source
        • Mice
        • Others
      • US Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • US Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • US Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • US Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • CANADA Outlook (USD Billion, 2019-2030)

      • CANADA Custom Antibody by Source
        • Mice
        • Others
      • CANADA Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • CANADA Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • CANADA Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • CANADA Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
    • Europe Outlook (USD Billion, 2019-2030)

      • Europe Custom Antibody by Source
        • Mice
        • Others
      • Europe Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Europe Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Europe Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Europe Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Germany Outlook (USD Billion, 2019-2030)

      • Germany Custom Antibody by Source
        • Mice
        • Others
      • Germany Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Germany Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Germany Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Germany Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • France Outlook (USD Billion, 2019-2030)

      • France Custom Antibody by Source
        • Mice
        • Others
      • France Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • France Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • France Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • France Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • UK Outlook (USD Billion, 2019-2030)

      • UK Custom Antibody by Source
        • Mice
        • Others
      • UK Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • UK Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • UK Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • UK Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • ITALY Outlook (USD Billion, 2019-2030)

      • ITALY Custom Antibody by Source
        • Mice
        • Others
      • ITALY Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • ITALY Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • ITALY Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • ITALY Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • SPAIN Outlook (USD Billion, 2019-2030)

      • Spain Custom Antibody by Source
        • Mice
        • Others
      • Spain Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Spain Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Spain Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Spain Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Rest Of Europe Outlook (USD Billion, 2019-2030)

      • Rest Of Europe Custom Antibody by Source
        • Mice
        • Others
      • REST OF EUROPE Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • REST OF EUROPE Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • REST OF EUROPE Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • REST OF EUROPE Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific Custom Antibody by Source
        • Mice
        • Others
      • Asia-Pacific Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Asia-Pacific Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Asia-Pacific Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Asia-Pacific Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • China Outlook (USD Billion, 2019-2030)

      • China Custom Antibody by Source
        • Mice
        • Others
      • China Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • China Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • China Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • China Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Japan Outlook (USD Billion, 2019-2030)

      • Japan Custom Antibody by Source
        • Mice
        • Others
      • Japan Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Japan Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Japan Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Japan Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • India Outlook (USD Billion, 2019-2030)

      • India Custom Antibody by Source
        • Mice
        • Others
      • India Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • India Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • India Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • India Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Australia Outlook (USD Billion, 2019-2030)

      • Australia Custom Antibody by Source
        • Mice
        • Others
      • Australia Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Australia Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Australia Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Australia Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific Custom Antibody by Source
        • Mice
        • Others
      • Rest of Asia-Pacific Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Rest of Asia-Pacific Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Rest of Asia-Pacific Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Rest of Asia-Pacific Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World Custom Antibody by Source
        • Mice
        • Others
      • Rest of the World Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Rest of the World Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Rest of the World Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Rest of the World Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East Custom Antibody by Source
        • Mice
        • Others
      • Middle East Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Middle East Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Middle East Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Middle East Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Africa Outlook (USD Billion, 2019-2030)

      • Africa Custom Antibody by Source
        • Mice
        • Others
      • Africa Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Africa Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Africa Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Africa Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America Custom Antibody by Source
        • Mice
        • Others
      • Latin America Custom Antibody by Service
        • Antibody Development
        • Antibody Production & Purification
        • Antibody Fragmentation & Labelling
      • Latin America Custom Antibody by Research Area
        • Oncology
        • Neurobiology
        • Infectious Diseases
        • Immunology
        • Others
      • Latin America Custom Antibody by End Users
        • Hospitals & Clinics
        • Academic & Research Institute
        • Contact Research Organization
        • Biotechnology Companies
        • Others
      • Latin America Custom Antibody by Type
        • Monoclonal Antibodies
        • Polyclonal Antibodies
        • Recombinant Antibody
        • Other Custom Antibodies
    Custom Antibody Market Research Report – Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials